Next-Gen Neurotechnologies: Graphene Electrodes and Magnetic Surgical Robotics in Deep Brain Neuromodulation
Dr. Dereck Mush, MD, MBA
Neuros Medical
Developing bioelectric nerve-block therapies for chronic pain management.
What they do
The company develops an implantable neuromodulation system designed to deliver high-frequency electrical stimulation to peripheral nerves. This technology blocks pain signals traveling to the brain, offering a non-opioid solution for patients suffering from chronic post-amputation pain.
The record
- Vertical
- Neurotech
- Sub-segment
- Neuromodulation
- Product type
- Device
- Stage
- Series C+
- Headquarters
- Aliso Viejo, USA
- Region
- North America
- Founded
- 2008
- Total funding
- $75M raised
Notable investors: U.S. Venture Partners, RiverVest Venture Partners, Aperture Venture Partners.
Also in Neurotech
Related on The Signal
Dr. Dereck Mush, MD, MBA